Inuki, Shinsuke
Hirata, Natsumi
Kashiwabara, Emi
Kishi, Junichiro
Aiba, Toshihiko
Teratani, Toshiaki
Nakamura, Wataru
Kojima, Yoshimi
Maruyama, Toru
Kanai, Takanori
Fujimoto, Yukari
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP16K16638, JP26882036, JP17H02207, JP18H04426, JP19H04815, JP17H05800)
Japan Agency for Medical Research and Development (P18ak0101072)
Mizutani Foundation for Glycoscience
Mishima Kaiun Memorial Foundation
Takeda Science Foundation
ERATO Murata Lipid Active Structure Project
Article History
Received: 24 March 2020
Accepted: 10 August 2020
First Online: 25 September 2020
Competing interests
: S.I., N.H., E.K., J.K., T.A. and Y.F. have applied a patent application, which includes a part of the manuscript as follows; “Compound or Salt Thereof, Natural Killer T Cell Activator, and Pharmaceutical Composition.” WO/2017/163808 (Keio University and REGiMMUNE Co, Ltd.). Other authors declare no competing interests.